| Ainsworth Dental Clinic Llc | |
|
255 N Maple St Ainsworth NE 69210-1420 | |
| (402) 387-2404 | |
| (402) 387-2410 |
| Full Name | Ainsworth Dental Clinic Llc |
|---|---|
| Speciality | Dentist - General Practice |
| Location | 255 N Maple St, Ainsworth, Nebraska |
| Authorized Official Name and Position | Frank David Patterson (DENTIST) |
| Authorized Official Contact | 4023872404 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Ainsworth Dental Clinic Llc 255 N Maple St Ainsworth NE 69210-1420 Ph: (402) 387-2404 | Ainsworth Dental Clinic Llc 255 N Maple St Ainsworth NE 69210-1420 Ph: (402) 387-2404 |
| NPI Number | 1457697153 |
|---|---|
| Provider Enumeration Date | 12/27/2012 |
| Last Update Date | 01/14/2013 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457697153 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | (* (Not Available)) | Primary |
News Archive
Fifty years after the first reported partial-ileal bypass, metabolic surgery has an established role in achieving weight loss and reducing cardiovascular death in obese patients.
Scientists at Johns Hopkins Medicine and the National Tsing Hua University in Taiwan say they have found a fast way to manipulate a cell's cilia, the tiny, fingerlike protrusions that "feel" and sense their microscopic environment.
In good news for patients with stubborn cases of ulcerative colitis, a serious intestinal disorder, a new research review suggests that the drug infliximab can be a useful alternative if other treatments don't work.
Agricultural subsidies are responsible for making those processed and energy-dense foods that contribute to the American epidemic of obesity the most affordable options for consumers, concludes a new study led by Dr. Mark J. Eisenberg, a cardiologist and epidemiologist at the Lady Davis Institute at the Jewish General Hospital in Montreal.
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, announced today that it has completed the sale of Bioniche Pharma Holdings Limited to Mylan Inc., a leading, global generic and specialty pharmaceutical company, for $550 million in cash.
› Verified 6 days ago